NCT05987774 · Stanford University
Improving Social Communication in Individuals With ASD Using AI
What this study is about
The purpose of this study is to identify whether researched and commonly used face-to-face interventions can be effectively implemented through artificial intelligence (AI) using an application on the phone or computer. The investigators plan to recruit verbal individuals diagnosed with autism spectrum disorder who demonstrate challenges with socialization.
View original scientific description
The purpose of this study is to identify whether researched and commonly used face-to-face interventions can be effectively implemented through artificial intelligence (AI) using an application on the phone or computer. The investigators plan to recruit verbal individuals diagnosed with autism spectrum disorder who demonstrate challenges with socialization. Modules focusing on various difficulties experienced by autistic individuals will provide practice and feedback using voice recognition and feedback. If effective, this intervention can be scaled up to provide cost-effective accessible assistance to individuals, particularly those who do not have access to care or prefer to secure services in the comfort of their own homes.
Interventions
DEVICE
AI Modules for Improving Social Conversation
The application if the modules will be delivered using software. These modules have been developed to provide feedback on specific areas following voice or text input (user preference will be recorded in case this effects the results). The investigators currently have developed AI modules for common social communication challenges exhibited by individuals with ASD. Examples include: Empathy (general and in the work setting), Asking Relevant Questions, Listen and Respond, Talking the right amount, giving the right amount of personal information, Tactful Responses, Giving compliments, and Staying on topic during Conversation. These are all areas that can be challenging for individuals diagnosed with autism spectrum disorder. AI modules consist of thousands of total training examples. Participants may access the modules on their phones or computers.
Primary outcome measures
Social Conversation Sample
Time frame: Approximately 9 weeks per participant (4 weeks of intervention + pre and post measures + 1-month follow-up)
Measured in terms of what percentage of responses (0% - 100%) during the investigators' social conversation sample are answered appropriately. Each of the participants' responses will be evaluated by a MA or PhD-level expert. Social conversation samples will be collected via zoom, audio recorded and computer transcribed, after which audio recordings will be erased. An initial sample will be collected at baseline, after four weeks of intervention, and at post-intervention.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Primary diagnosis of autism spectrum disorder (ASD)
- Age between 11 to 35
- Ability to engage in social conversation using full sentences for a 20 minute period
- Verbal communication difficulties in an individual targeted area (e.g., empathy) as measured on the conversation sample Participants with a co-occuring diagnosis of ADHD, depression, or social anxiety will not be excluded since these are very common in this population and are often related to or a bi-product of difficulties with social conversation.
Exclusion criteria
- Non-documented or self-diagnosis of ASD
- At or above 60% correct responding on targeted area of social conversation during conversation probe
- No access to phone or computer for intervention sessions
- Inability to carry on a conversation during the conversation probe
- Apparent intellectual impairment that interferes with the ability to carry on a conversation (e.g., responds only in single words or does not respond to conversation, lack of understanding of questions or content during conversation probe)
- Non English speaking
- Serious medical or psychiatric issues that may interfere with conversation or the ability to complete the program
- Lack of interest in participating.
Where
- Stanford, California
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced May 22, 2024 · Source of record for eligibility and locations